Patients, your care and safety are our top priorities! We encourage you to follow CDC guidelines to self- quarantine if you are experiencing symptoms
consistent with COVID-19. Please do not hesitate to call us to assess whether to reschedule your appointment. Please call 716-631-2500.


Windsong Partners with the University at Buffalo in Breast Cancer Research

Windsong Breast Care in conjunction with the School of Public Health and Health Professions at the University at Buffalo is recruiting women to participate in a Microbiome Breast Ecology research study -a study of the microbiome- the bacteria and other single cell organisms that are found normally in every part of the body. The microbiome affects many diseases and the study will determine how it affects breast cancer to better understand cancer prevention and treatment.

The study is limited to those women whose surgery will be conducted at Millard Fillmore Suburban Hospital. Women who are interested in participating have to be at least 35 years old and should contact the study Project Manager, Rosa Bordonaro at 716-829-5603 or or Windsong's Breast Navigators at 716-631-2500 ext. 2115.

Windsong has also worked with UB on another research opportunity, through collaboration with Dr. Jun Xia's lab in Department of Biomedical Engineering at UB Jacobs School of Medicine and Biomedical Science. The scientists at UB are working on development of a new imaging device for breast imaging. It is a photoacoustic system called Dual Scan Mammoscope (DSM), which uses laser light and ultrasound to image the breast. The purpose of the study is to collect clinical data to evaluate for cancer detection efficiency with this new device, and also to compare to the existing clinical imaging techniques, such as breast MRI, ultrasound and mammogram.

This research was initially generously funded by a grant from the Komen Foundation, and it has recently received a new $1.4 million grant from the National Institutes of Health Institute of Biomedical Imaging and Bioengineering to continue its work on developing the DSM.

Currently, Windsong is assisting the researchers in identifying as many as the 180 breast cancer patients needed for the study. If you are interested in learning more regarding eligibility or participating, please contact Windsong's Breast Navigators as 716-631-2500 ext. 2115.

© 2021 WindsongWNY  |  Platform Privacy Policy  |  Notice of Privacy Practices (EN) (ES)
Notice of Non-Discrimination (NND)  |  Terms of Use  |  Social Media Policy  |  US Radiology